Research & Development

2013福利彩票开奖79期2013彩票充20送202014080彩票排三杀码港股交投清淡 筑底行情或将延续


  之所以會對曹氏,雲氏下手,最大的可能性不是侵佔,而是割裂!   癆病會過人的,所以,甦稚不允許別人靠近衛青。2013福利彩票开奖79期   劉徹一開口,就讓雲瑯沒了跟他講任何道理的心情。2013彩票充20送20   雲瑯笑了,抱了一下可憐的曹襄,就會去睡覺了,天寒地凍的,抱著溫香軟玉的甦稚要比跟曹襄一起喝冷風要好的多。   “陛下在干什麼?”2014080彩票排三杀码   雲瑯嘆口氣道︰“多年以來,母親都是手握大權的人,她已經習慣性的把自己的一切獻給大漢帝國了。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo